ArticleeNeurologicalSci2025

Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study.

Kunihisa MiwaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.